Market Tracker

08/28 6:01pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

42.25
Delayed Data
As of Aug 28
 +1.01 / +2.45%
Today’s Change
30.05
Today|||52-Week Range
52.33
+31.50%
Year-to-Date

Today’s Trading

Previous close41.24
Today’s open40.97
Day’s range40.97 - 42.25
Volume537,047
Average volume (3 months)864,935
Market cap$5.3B
Dividend yield--
Data as of 4:14pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-56.34%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+6.50%
P/E ratioNM
Price/Sales13.83
Price/Book24.84

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC-0.19-0.62%
TAROTaro Pharmaceutical ...+0.30+0.22%
AKRXAkorn Inc-0.18-0.44%
ANACAnacor Pharmaceutica...+1.83+1.37%
Data as of 4:04pm ET, 08/28/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$286.8M
Annual profit (last year)-$76.1M
Net profit margin-26.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts